EA201400740A1 - PHARMACEUTICAL COMPOSITIONS OF SEVELAMERA - Google Patents

PHARMACEUTICAL COMPOSITIONS OF SEVELAMERA

Info

Publication number
EA201400740A1
EA201400740A1 EA201400740A EA201400740A EA201400740A1 EA 201400740 A1 EA201400740 A1 EA 201400740A1 EA 201400740 A EA201400740 A EA 201400740A EA 201400740 A EA201400740 A EA 201400740A EA 201400740 A1 EA201400740 A1 EA 201400740A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sevelamera
pharmaceutical compositions
core
tablets
medicine
Prior art date
Application number
EA201400740A
Other languages
Russian (ru)
Inventor
Нильс Яп Осинга
Original Assignee
Синтон Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Синтон Б.В. filed Critical Синтон Б.В.
Priority to EA201400740A priority Critical patent/EA201400740A1/en
Publication of EA201400740A1 publication Critical patent/EA201400740A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к фармацевтической таблетке с немедленным высвобождением, включающей ядро, содержащее 70-85 мас.% севеламера карбоната, в пересчете на безводное соединение, 10-25 мас.% лактозы моногидрата и дополнительно растворимую в воде пленочную оболочку, окружающую ядро, к способу получения таких таблеток, к их использованию в медицине и к использованию привитого сополимера поливинилового спирта-полиэтиленгликоля для получения таблеток, покрытых оболочкой.The invention relates to a pharmaceutical tablet with immediate release, comprising a core containing 70-85 wt.% Sevelamer carbonate, in terms of anhydrous compound, 10-25 wt.% Lactose monohydrate and additionally water-soluble film shell surrounding the core, to the method of obtaining such tablets, to their use in medicine and to the use of a graft copolymer of polyvinyl alcohol-polyethylene glycol for the preparation of coated tablets.

EA201400740A 2009-10-22 2009-10-22 PHARMACEUTICAL COMPOSITIONS OF SEVELAMERA EA201400740A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201400740A EA201400740A1 (en) 2009-10-22 2009-10-22 PHARMACEUTICAL COMPOSITIONS OF SEVELAMERA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201400740A EA201400740A1 (en) 2009-10-22 2009-10-22 PHARMACEUTICAL COMPOSITIONS OF SEVELAMERA

Publications (1)

Publication Number Publication Date
EA201400740A1 true EA201400740A1 (en) 2014-09-30

Family

ID=51628544

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400740A EA201400740A1 (en) 2009-10-22 2009-10-22 PHARMACEUTICAL COMPOSITIONS OF SEVELAMERA

Country Status (1)

Country Link
EA (1) EA201400740A1 (en)

Similar Documents

Publication Publication Date Title
EA201270581A1 (en) PHARMACEUTICAL COMPOSITIONS OF SEVELAMERA
TN2010000152A1 (en) Pharmaceutical compositions
MX369121B (en) Aqueous pharmaceutical formulation of tapentadol for oral administration.
MX336038B (en) Controlled release pharmaceutical compositions of tapentadol.
BR112012024139A2 (en) double-layer pharmaceutical formulations containing opioid agonists and antagonists.
EA201290982A1 (en) PHARMACEUTICAL COMPOSITIONS, PREVENTING ABUSE
WO2011101866A3 (en) Gastric retention formulation containing baclofen
MX2013001985A (en) Nalbuphine-based formulations and uses thereof
UY33076A (en) FEXOFENADINE MICROCAKES AND COMPOSITIONS CONTAINING THEM
EA201171497A1 (en) REDUCTION OF OPIOID FLUCTUATIONS IN THE BLOOD
NZ594311A (en) Pharmaceutical composition comprising tamsulosin and solifenacin for oral administration
PH12015500823A1 (en) Modified release formulations for oprozomib
MX347105B (en) Pharmaceutical compositions comprising hydromorphone and naloxone.
PL3793534T3 (en) An oral tablet for delivery of active ingredients to the gastrointestinal tract
TN2012000507A1 (en) Enteric tablet
EP2384746A3 (en) Dual release oral tablet compositions of dexlansoprazole
PH12016500693A1 (en) Slow-release solid oral compositions
EA201400740A1 (en) PHARMACEUTICAL COMPOSITIONS OF SEVELAMERA
EA201590732A1 (en) DISPENSABLE TABLET
TR201005241A1 (en) Pregabalin solution formulation for controlled release.
TR201109159A2 (en) Film-coated tablet composition containing eplerenone.
WO2010035245A3 (en) Extended release dosage form of ropinirole
TR201010859A2 (en) Tablet forms containing cefdinir.
UA105675C2 (en) Benzodiazepine bromodomain inhibitor
TW200833375A (en) Pharmaceutical compositions